Advanced search

Efficacy and safety of Infliximab in patients with active spondyloarthritis: results of a long-term follow-up study

Author
Organization

Citation

Please use this url to cite or link to this publication:

Chicago
DEVINCK, MIEKE, PHILIPPE CARRON, Herman Mielants, and Filip Van den Bosch. 2010. “Efficacy and Safety of Infliximab in Patients with Active Spondyloarthritis: Results of a Long-term Follow-up Study.” In Clinical and Experimental Rheumatology, 28:623–623.
APA
DEVINCK, M., CARRON, P., Mielants, H., & Van den Bosch, F. (2010). Efficacy and safety of Infliximab in patients with active spondyloarthritis: results of a long-term follow-up study. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY (Vol. 28, pp. 623–623). Presented at the 14th International conference on Behcet’s disease.
Vancouver
1.
DEVINCK M, CARRON P, Mielants H, Van den Bosch F. Efficacy and safety of Infliximab in patients with active spondyloarthritis: results of a long-term follow-up study. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2010. p. 623–623.
MLA
DEVINCK, MIEKE, PHILIPPE CARRON, Herman Mielants, et al. “Efficacy and Safety of Infliximab in Patients with Active Spondyloarthritis: Results of a Long-term Follow-up Study.” Clinical and Experimental Rheumatology. Vol. 28. 2010. 623–623. Print.
@inproceedings{1095153,
  author       = {DEVINCK, MIEKE and CARRON, PHILIPPE and Mielants, Herman and Van den Bosch, Filip},
  booktitle    = {CLINICAL AND EXPERIMENTAL RHEUMATOLOGY},
  issn         = {0392-856X},
  language     = {eng},
  location     = {London, UK},
  number       = {4},
  pages        = {623--623},
  title        = {Efficacy and safety of Infliximab in patients with active spondyloarthritis: results of a long-term follow-up study},
  volume       = {28},
  year         = {2010},
}

Web of Science
Times cited: